Does the magnitude of the beneficial effect of beta-blockers in chronic heart failure differ between diabetic and nondiabetic patients? A meta-analysis of all-cause mortality outcomes from major chronic heart failure beta-blocker trials
Data(s) |
01/01/2003
|
---|---|
Identificador | |
Idioma(s) |
eng |
Publicador |
Elsevier Science Inc |
Palavras-Chave | #Cardiac & Cardiovascular Systems #11 Medical and Health Sciences |
Tipo |
Conference Paper |